NCT05177978 is a NA clinical trial of Phosphatidylserine in Cognitive Change, sponsored by Northumbria University.

Who is sponsoring NCT05177978?

NCT05177978 is sponsored by Northumbria University.

What drugs are being tested in NCT05177978?

Interventions in NCT05177978: Phosphatidylserine, Placebo.

What condition does NCT05177978 study?

NCT05177978 studies Cognitive Change.

Is NCT05177978 still recruiting?

NCT05177978 is currently completed. Last updated 28 September 2022.

Last reviewed 2022-09-28 · How we verify

NCT05177978

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years

Completed NA Last updated 28 September 2022

What this trial tests

NA trial testing Phosphatidylserine in Cognitive Change in 208 participants. Completed in 14 August 2022.

Timeline

2 November 2020

Primary endpoint
14 August 2022

14 August 2022

Quick facts

Lead sponsor	Northumbria University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	basic science
Enrollment	208
Start date	2 November 2020
Primary completion	14 August 2022
Estimated completion	14 August 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Phosphatidylserine
Placebo

Conditions studied

Cognitive Change — all drugs for Cognitive Change →

Sponsor

Northumbria University

Who can join

Adults 8 to 12, any sex, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the cognitive effects (attention, learning, and memory) of 6 and 12 weeks administration of a supplement containing phosphatidylserine in comparison to a placebo in healthy children aged 8 to 12 years old. The study will utilize Rey Auditory Verbal Learning Test (RAVLT) and Computerised Mental Performance Assessment System (COMPASS, Northumbria University) for a broad assessment of cognitive function/learning, and actigraphy to monitor sleep.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial.
Friling M, Jackson PA, Kennedy D, Dodd F, et al · · 2025 · PMID 41318468 · DOI 10.1186/s12937-025-01264-9

Verify or expand the search:

Other trials of Phosphatidylserine

Trials testing the same drug.

NCT04557228 — ADAM17 and Vascular Function in Diabetes · NA · active not recruiting
NCT04920305 — Phosphatidylserine Improves Cognitive Function in the Elderly · NA · unknown
NCT04967404 — The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists · NA · unknown

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

NCT07147894 — Executive Function Training for Children and Adolescents · NA · recruiting
NCT07383324 — Heat Stress in Individuals With Schizophrenia · NA · recruiting
NCT07261202 — Impact of Indoor Overheating on Physiological Strain in Children · NA · recruiting
NCT07267598 — Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults · NA · recruiting
NCT07054723 — Surviving Daily Life · recruiting

Other Northumbria University trials

Trials by the same sponsor.

NCT07501611 — Acute Cardiovascular Effects of Transcutaneous Auricular Vagus Nerve Stimulation · NA · not yet recruiting
NCT07242430 — 12-week Multi-vitamin/Mineral Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being · NA · not yet recruiting
NCT07235878 — 12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being · NA · not yet recruiting
NCT07297485 — Evaluating the Level of Agreement Between Goniometer Measurements and Algorithm to Determine Wall Squat Position · completed
NCT06967454 — Manipulation of Whey Permeate Formulation for Better Fluid Retention. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05177978 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northumbria University
Last refreshed: 28 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05177978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing